Fan, M., Zhao, X., Qi, J., Jiang, Y., Liu, B., Dun, Z., . . . Pang, Q. (2020). TRIM31 enhances chemoresistance in glioblastoma through activation of the PI3K/Akt signaling pathway. Experimental and therapeutic medicine, 20(2), 802-809. https://doi.org/10.3892/etm.2020.8782
Chicago Style (17th ed.) CitationFan, Ming‑De, Xue‑Ying Zhao, Jian‑Ni Qi, Yang Jiang, Bing‑Yu Liu, Zhi‑Ping Dun, Rui Zhang, Cheng‑Wei Wang, and Qi Pang. "TRIM31 Enhances Chemoresistance in Glioblastoma Through Activation of the PI3K/Akt Signaling Pathway." Experimental and Therapeutic Medicine 20, no. 2 (2020): 802-809. https://doi.org/10.3892/etm.2020.8782.
MLA (9th ed.) CitationFan, Ming‑De, et al. "TRIM31 Enhances Chemoresistance in Glioblastoma Through Activation of the PI3K/Akt Signaling Pathway." Experimental and Therapeutic Medicine, vol. 20, no. 2, 2020, pp. 802-809, https://doi.org/10.3892/etm.2020.8782.